Skip to main content

Clinical Products

Clinical Products

  • MAESTRIA™

    New Generation Microbiology Middleware

    An innovative, integrated software solution designed to orchestrate your lab routine and transform data into insights.

  • MYACUTECASE™ Mobile App

    All the information you need for confident clinical decision- making with the VIDAS® Emergency & Critical Care assays

    Designed for healthcare professionals, MYACUTECASE™ is a first-of-its-kind app. Used in conjunction with clinical assessment and other laboratory findings, it provides comprehensive biomarker information and useful tools for:

  • PREVI® COLOR GRAM

    A Market-Leading Automated Gram Stainer Offering Confidence in Results

    Gram staining is a key step in your microbiology workflow, and PREVI® COLOR GRAM is the system to streamline it and provide timely staining results for impactful decisions.

  • RAL® STAINER

    Secures Your AFB Staining and Eases Slide Reading

    Easier and faster reading and no daily maintenance with RAL® STAINER. This closed fully automated bath system offers a unique fixative solution that prevents any cross-contamination.

  • RAPIDEC® CARBA NP

    Rapid, Reliable Test for Carbapenemase-Producing Bacteria

    High medical value test confirms Carbanemase-producing Gram-negative bacilli in agar cultures with reliable results in under 2 hours. This test is a quick and easy way to control carbapenemase producers and meet diagnostic and screening challenges, improving patient management and controlling HAI.

  • SARS-COV-2 FLUA/FLUB/RSV R-GENE®

    Real-time PCR detection kit

    Detect & differentiate SARS-CoV-2, Influenza A, Influenza B and RSV in 1 PCR test.

  • STOOL PREPROCESSING DEVICE

    Stool preprocessing for molecular testing

    Stool preprocessing device enabling standardized stool sample preparation for nucleic acid extraction of viruses, bacteria and parasites in about 5 minutes.

    • TTV R-GENE® 

      Guiding Transplant Risk Management

      Real-time PCR assay for Torque Teno Virus detection and quantification to support transplant management.

    • VIDAS® 3

      Trusted. Robust. Innovative.

      With its advanced immunoassay technology and optimized testing protocols, the fully automated VIDAS® 3 benchtop immunoanalyzer empowers your lab with confidence, offering the precise results you need, when you need them. 

    • VIDAS® Arboviruses Panel

      Suspecting an Arbovirus? Think Dengue and Chikungunya

      Our VIDAS® offer of immunoassays directed against arboviruses diseases improve access to medically important automated diagnostic tests. 

    • VIDAS® BONE & MINERAL METABOLISM

      Our VIDAS® Bone & Mineral Metabolism assays offer a complete solution for the diagnosis of chronic kidney diseases, the determination of vitamin D, and iron deficiency.

    • VIDAS® ANEMIA PANEL

      Our VIDAS® Anemia assays provide a comprehensive solution for diagnosing multiple causes of anemia, including iron deficiency, vitamin B12 deficiency and anemia related to chronic diseases.

    • VIDAS® C. difficile Panel

      Rapid identification of C. difficile infection

      The VIDAS® C. difficile Panel includes two complementary tests that aid in the diagnosis of C. difficile infection. 

    • VIDAS® Cardiac Assays

      Improve Patient Outcomes and Optimize Patient Management in the Emergency Department

      An easy access to innovative cardiac tests for acute and complex situations to deliver reliable, fast, and actionable results to clinicians. bioMérieux with VIDAS® provides a comprehensive emergency & critical care offer for better patient with cardiovascular disease management in the emergency department.

    • VIDAS® D-DIMER EXCLUSION™ II

      Safe Exclusion of Venous Thromboembolism

      VIDAS® D-Dimer Exclusion™ II is a highly-sensitive automated D-Dimer assay. Used in conjunction with assessment of clinical pretest probability, it allows safe exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE) in both low and intermediate suspected outpatient risk groups in just 20 minutes.